Finance

Lists
7AY1:FRA
Actinium Pharmaceuticals Inc
€1.24
-0.32%
(-0.0040) 1D
Oct 21, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 7AY1...
Open
€1.24
High
€1.24
Low
€1.24
Mkt. cap
43.39M
Avg. vol.
93.00
Volume
0.00
52-wk high
€1.43
52-wk low
€0.63
No. of employees
27
Open
€1.24
High
€1.24
Low
€1.24
Mkt. cap
43.39M
Avg. vol.
93.00
Volume
0.00
52-wk high
€1.43
52-wk low
€0.63
No. of employees
27
News stories
From web sources and news partners
About Actinium Pharmaceuticals Inc
CEOSandesh Seth
Employees27
Founded2000
Headquarters-
SectorBiotechnology
Websiteactiniumpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
90.00K
-
-
35.00M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.25M
4.30M
4.20M
5.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.53M
2.12M
1.70M
2.06M
Operating expense
5.78M
6.41M
5.90M
7.44M
Total operating expenses
5.78M
6.41M
5.90M
7.44M
Operating income
-5.69M
-6.41M
-5.90M
27.56M
Other non operating income
-
-
-
-
EBT including unusual items
-5.13M
-5.94M
-5.52M
27.90M
EBT excluding unusual items
-5.13M
-5.94M
-5.52M
27.90M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.13M
-5.94M
-5.52M
27.90M
Net profit margin
-5,701.11%
-
-
79.72%
Earnings per share
-0.16
-0.19
-0.18
0.89
Interest and investment income
561.00K
474.00K
381.00K
336.00K
Interest expense
-
-
-
-
Net interest expenses
561.00K
474.00K
381.00K
336.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.49M
-6.37M
-5.87M
28.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps